Stelkast Generic Knee Instruments
Payments companies reported to CMS as associated with Stelkast Generic Knee Instruments. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Stelkast Generic Knee Instruments, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Stelkast Generic Knee Instruments
These are the largest totals companies reported as associated with Stelkast Generic Knee Instruments. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dennis Pfisterer | Teaneck, NJ | Orthopaedic Surgery | $266.93 |
| Michael Gustavel | Boise, ID | Sports Medicine (Orthopaedic Surgery) | $175.39 |
| Michael Daines | Caldwell, ID | Orthopaedic Surgery | $175.39 |
| Paul Montalbano | Boise, ID | Neurological Surgery | $175.39 |
| Alan Rechter | Houston, TX | Orthopaedic Surgery | $172.91 |
| Matthew Mendez-Zfass | New York, NY | Sports Medicine (Orthopaedic Surgery) | $127.38 |
| Eleonora Walczak | New York, NY | Surgical | $127.38 |
| Max Willinger | Wayne, NJ | Orthopaedic Surgery | $108.93 |
| Katherine Zimmerman | Rochester, MN | Orthopaedic Surgery | $105.73 |
| Michael Suk | Danville, PA | Orthopaedic Surgery | $99.98 |
Prescribed Stelkast Generic Knee Instruments?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.